Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Gossamer Bio Inc (NASDAQ: GOSS) closed at $2.38 down -2.46% from its previous closing price of $2.44. In other words, the price has decreased by -$2.46 from its previous closing price. On the day, 2.26 million shares were traded. GOSS stock price reached its highest trading level at $2.42 during the session, while it also had its lowest trading level at $2.31.
Ratios:
For a deeper understanding of Gossamer Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.40 and its Current Ratio is at 4.40.
On July 14, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $11.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $9.Oppenheimer initiated its Outperform rating on June 25, 2024, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 19 ’25 when Milligan Sandra bought 26,050 shares for $1.92 per share. The transaction valued at 50,016 led to the insider holds 58,050 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 558468672 and an Enterprise Value of 531080864. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.45. Its current Enterprise Value per Revenue stands at 13.199 whereas that against EBITDA is -3.655.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.87, which has changed by 1.4536083 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $3.60, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -5.60%, while the 200-Day Moving Average is calculated to be 55.53%.
Shares Statistics:
For the past three months, GOSS has traded an average of 3.84M shares per day and 3355410 over the past ten days. A total of 227.32M shares are outstanding, with a floating share count of 181.40M. Insiders hold about 20.22% of the company’s shares, while institutions hold 61.59% stake in the company. Shares short for GOSS as of 1759190400 were 27397216 with a Short Ratio of 7.13, compared to 1756425600 on 22046902. Therefore, it implies a Short% of Shares Outstanding of 27397216 and a Short% of Float of 12.740000000000002.
Earnings Estimates
Gossamer Bio Inc (GOSS) is presently subject to a detailed evaluation by 7.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.58 and -$0.77 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.56, with 7.0 analysts recommending between -$0.11 and -$0.89.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for GOSS’s current fiscal year. The highest revenue estimate was $66.8M, while the lowest revenue estimate was $21.38M, resulting in an average revenue estimate of $37.2M. In the same quarter a year ago, actual revenue was $114.7M
